Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,380
-690 (-4.04%)
Mar 9, 2026, 3:30 PM KST
9.05%
Market Cap 177.58B
Revenue (ttm) 179.98B
Net Income (ttm) -700.38M
Shares Out 10.84M
EPS (ttm) -65.98
PE Ratio n/a
Forward PE 15.93
Dividend 300.00 (1.76%)
Ex-Dividend Date Dec 29, 2025
Volume 47,499
Average Volume 56,006
Open 16,510
Previous Close 17,070
Day's Range 16,030 - 17,210
52-Week Range 14,720 - 20,900
Beta 0.74
RSI 42.34
Earnings Date Feb 13, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 475
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.

Financial Statements

News

There is no news available yet.